...
首页> 外文期刊>Toxicology in vitro: an international journal published in association with BIBRA >Use of differential display-polymerase chain reaction to identify genes selectively modulated by chemical allergens in reconstituted human epidermis.
【24h】

Use of differential display-polymerase chain reaction to identify genes selectively modulated by chemical allergens in reconstituted human epidermis.

机译:差异显示聚合酶链反应在鉴定重组人表皮中由化学变应原选择性调节的基因中的应用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In the screening of topical drugs, cosmetics and other chemicals for human use, it is very important, both from a safety and an economic point of view, to have biological markers to discriminate irritant and allergic contact dermatitis that have different impacts on human health. Owing to their anatomical location, keratinocytes are among the first cells to be exposed to various antigens and the use of these cells as a simplified in vitro model to evaluate the potential toxicity of chemicals destined for cutaneous application is amply justified. The purpose of this work was to identify new genes selectively modulated by skin toxicants. Commercially available reconstituted human epidermis (Epiderm(TM)) was treated for 18 h with sodium dodecyl sulfate (SDS) 0.4 mg/ml, as reference irritant, or with dinitrochlorobenzene (DNCB) 0.2 mg/ml, as reference allergen, or with vehicle control. Differential display PCR (DD-PCR) was performed. Results identified adipose differentiation-related protein (ADRP) as up-regulated by both irritant and allergen, and KIAA0368 as selectively up-regulated by contact allergen. These data indicate the enormous potential of functional genomic techniques, which allow the identification of genes not immediately connected with the immune response, or even novel genes with unknown functions, which nevertheless may be potential markers of skin irritation and allergy.
机译:从安全和经济的角度来看,在筛选局部使用的药物,化妆品和其他化学物质时,从生物学和安全角度来看,区分对人类健康有不同影响的刺激性和过敏性接触性皮炎非常重要。由于其解剖学位置,角质形成细胞是最早暴露于各种抗原的细胞之一,因此有充分理由证明将这些细胞用作简化的体外模型来评估注定用于皮肤的化学物质的潜在毒性。这项工作的目的是确定由皮肤有毒物质选择性调节的新基因。用0.4 mg / ml的十二烷基硫酸钠(SDS)作为参比刺激物,或0.2 mg / ml的二硝基氯苯(DNCB)作为参比过敏原,或用赋形剂处理市售的重组人表皮(Epiderm™)18 h控制。进行差异显示PCR(DD-PCR)。结果确定,脂肪分化相关蛋白(ADRP)被刺激性和过敏原均上调,而KIAA0368被接触性过敏原选择性地上调。这些数据表明功能基因组技术的巨大潜力,可用于鉴定与免疫反应不立即相关的基因,甚至是功能未知的新基因,但它们仍可能是皮肤刺激和过敏的潜在标志。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号